REPLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
Replimune Group, Inc.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$11.05+0.19 (+1.75%)
Close on Oct 19, 2026
- Market cap
- $1.07B
- P/E (TTM)
- –
- Dividend yield
- –
Margins need revenue and profit figures
This company does not report the lines needed to calculate margins.
Growth rates
Compound annual growth to fiscal 2026
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2017 | FY2021 | FY2026 | Trend |
|---|---|---|---|---|
| Return on equity | – | -23.7% | -107.9% | |
| Return on assets | – | -20.8% | -71.0% | |
| Current ratio | – | 33.25 | 4.79 | |
| Debt to equity | – | – | 0.50 | |
| Net debt to EBITDA | – | – | 0.40× | |
| Interest coverage | – | -97.7× | -47.1× | |
| Diluted shares | 5M | 46M | 93M |
Where the cash went
Fiscal 2022 to 2026, five years combined
Replimune generated $868.29M from operations and spent $21.18M on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
Generated
$868.29M
Used
$21.18M
Capital expenditure$21.18M100%Dividends$00%Share buybacks$00%
DuPont needs revenue, assets and equity
This company does not report all three for consecutive years.
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2026 against fiscal 2025
1of 7 tests passed in fiscal 2026. Some tests lack the figures they need.
- ProfitableNet income above zero-$313.94M
- Cash generatingOperating cash flow above zero-$280.34M
- Return on assets improvedROA up on the prior year-50.7% → -56.9%
- Earnings backed by cashOperating cash flow above net income-$280.34M vs -$313.94M
- Less leverageLong-term debt to assets fell8.4% → 25.1%
- Better liquidityCurrent ratio rose7.95 → 4.79
- No dilutionShare count did not rise81M → 93M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose– → –